close

INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Merit Medical Systems, Inc.

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

The law firm of Kirby McInerney LLP is investigating claims against Merit Medical Systems, Inc. (“Merit Medical” or the “Company”) (NASDAQ: MMSI). The investigation focuses on whether the Company’s board of directors has breached its fiduciary duties to the Company.

If you purchased or otherwise acquired Merit Medical securities, have information, or would like to learn more about these claims, please contact Thomas W. Elrod of Kirby McInerney LLP at 212-371-6600, by email at investigations@kmllp.com, or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website: http://www.kmllp.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  264.32
-0.69 (-0.26%)
AAPL  302.04
-0.21 (-0.07%)
AMD  435.24
-12.34 (-2.76%)
BAC  50.95
-0.28 (-0.56%)
GOOG  385.33
+0.44 (0.11%)
META  599.52
-5.53 (-0.91%)
MSFT  418.26
-2.80 (-0.66%)
NVDA  219.22
-4.25 (-1.90%)
ORCL  189.57
+1.41 (0.75%)
TSLA  414.76
-2.50 (-0.60%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today